Captopril prevention project--what shall we do about captopril and the risk of stroke?

Nephrol Dial Transplant. 2000 Jan;15(1):2-5. doi: 10.1093/ndt/15.1.2.
No abstract available

Publication types

  • Clinical Trial
  • Editorial
  • Randomized Controlled Trial
  • Review

MeSH terms

  • Angiotensin II / pharmacology
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology*
  • Animals
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use
  • Brain Ischemia / prevention & control
  • Captopril / pharmacology*
  • Humans
  • Hypertension / drug therapy
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Stroke / prevention & control*

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Angiotensin II
  • Captopril